NIH: Investigational ChAdOx1 nCoV-19 vaccine protects monkeys against COVID-19 pneumonia

A single dose of ChAdOx1 nCoV-19, an investigational vaccine against SARS-CoV-2, has protected six rhesus macaques from pneumonia caused by the virus, according to National Institutes of Health scientists and University of Oxford collaborators. SARS-CoV-2 is the virus that causes COVID-19.







The researchers posted their data to the preprint serverbioRxiv(link is external). The findings are not yet peer-reviewed but are being shared to assist the public health response to COVID-19. Based on these data, a Phase 1 trial of the candidate vaccine began on April 23 in healthy volunteers in the United Kingdom. CLICK HERE.

1 view
  • LinkedIn - Black Circle
  • Facebook - Black Circle
  • Twitter - Black Circle

Find It Fast

Scimedico L.L.C.

T: 908.986.3000 

F: 480.275.3317

E: info@scimedico.com

Mailing:

623 Eagle Rock Avenue 

West Orange, NJ 07052

Headquarters:

210 Bellevue Avenue

Montclair, NJ 07043

© 2020 Scimedico, LLC